Drug firm Jubilant Life Sciences today said it has raised Rs 50 crore through issuing commercial papers.
“The company has issued commercial papers for an aggregate amount of Rs 50 crore on October 14, 2016, having maturity date of December 20, 2016,” Jubilant said in a BSE filing.
“The aggregate amount of commercial papers outstanding as on date is Rs 50 crore,” it said.
Jubilant stock closed at Rs 648.10 per scrip, up 0.79 per cent, on the BSE.